Telehealth Rheumatology Visit Note

Date of Service: [Date]

Patient: [Full name]

DOB: [MM/DD/YYYY]

Provider: [Name, credentials]

Encounter Type: Telehealth Rheumatology Visit

Modality: [Audio-video / Audio-only with reason]

Patient Location: [City, State; home / facility]

Provider Location: [City, State]

Visit Participants: [Patient alone / Patient with caregiver / Interpreter present (language)]

Telehealth Attestation

This synchronous real-time telehealth visit was conducted via [platform name]. Patient identity was verified using two identifiers: [identifier 1], [identifier 2]. Patient provided [verbal / written] consent to proceed with telehealth. Patient confirmed [private setting / acknowledged privacy limitations]. Physical examination is limited by the telehealth format; elements not directly assessable today include [joint palpation / auscultation / precise joint warmth assessment / comprehensive neurologic exam / orthostatic vitals / other].

(If any required attestation element cannot be confirmed, insert "[COMPLETION REQUIRED: specify element]" rather than omitting.)

Subjective

Chief Complaint: [Patient's own words or concise clinical label]

History of Present Illness: [Narrative summary of established or working rheumatologic diagnosis, interval course since last visit, and today's primary concerns. Include flares, infections, hospitalizations, new diagnoses, and relevant context. Characterize pain location and character, morning stiffness duration, patient-reported swelling, fatigue, and functional limitations. Document any red flags warranting in-person evaluation. If patient-reported outcomes were collected, include instrument name, score, and collection method. Label any patient-reported joint counts as such and note validation limitations if used in composite scores.]

Medications and Monitoring: [Current rheumatologic medications including DMARDs, biologics, JAK inhibitors, glucocorticoids with taper plan if applicable. Include safety monitoring snapshot: last labs with date and key results, next labs due, infection screening status if initiating or changing immunosuppression, ophthalmology monitoring date if on antimalarials.] (If monitoring labs are overdue or unknown, explicitly state this and document plan to obtain.)

Review of Systems: [Targeted ROS: positives as detailed in HPI, otherwise negative except for specifically relevant findings. Focus on constitutional symptoms, mucocutaneous findings, cardiopulmonary symptoms, and infection risk indicators as applicable.]

Objective

Vitals: [Patient-reported vitals with device type if available; otherwise state "Vitals not available via telehealth."] (Do not estimate or fabricate values.)

Telehealth Examination:

• General: [Appearance, distress level, ability to converse, mobility within camera frame]
• Respiratory: [Observed effort, work of breathing, ability to speak in full sentences]
• Skin: [Visible rashes, lesions, nail changes; patient-provided photos with date if applicable]
• Musculoskeletal: [Clinician-observed via video: visible swelling, deformities, range of motion, gait. Patient-performed maneuvers with instructions given. Patient-reported findings to self-palpation clearly labeled as patient-reported.]
• Neuro/Psych: [Orientation, speech, affect, gross motor function as observed] (Limited by telehealth.)

(Acknowledge telehealth exam limitations. If objective inflammatory assessment is required for diagnosis or major treatment decisions, document that in-person evaluation is indicated.)

Data Reviewed: [Laboratories, imaging, outside records, and patient-provided photos with dates, tied to clinical reasoning.]

Assessment

(List problems in order of clinical importance. For each, include working diagnosis or differential, current status as stable/improving/worsening/flare, and key supporting findings with explicit attribution to patient report vs observed vs laboratory data. If diagnostic certainty is limited by telehealth constraints, state this and note whether in-person evaluation was discussed.)

[Problem]: [Working diagnosis or differential] — [Status: stable / improving / worsening / flare]. [Supporting data with attribution to patient-reported, observed exam, or laboratory/imaging findings. Note any telehealth limitations affecting diagnostic certainty.]

(Repeat for additional problems as needed.)

Plan

(Organize by problem with actionable items.)

[Problem]: [Medication changes with dose/route/frequency; steroid taper schedule if applicable; monitoring plan with specific labs and timing; non-pharmacologic recommendations; shared decision-making noting options discussed and patient preferences; safety-net instructions including infection precautions and when to seek urgent care; follow-up timing and modality with rationale for telehealth vs in-person.]

(Repeat for additional problems. When in-person follow-up is clinically indicated, state this explicitly.)

Follow-up: [Timeframe] via [telehealth / in-person] (Include rationale for modality choice and any pre-visit labs required.)